AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome. [PDF]
Nimani S +37 more
europepmc +1 more source
Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. [PDF]
Huang M +12 more
europepmc +1 more source
The Uncommon Phenomenon of Short QT Syndrome: A Scoping Review of the Literature. [PDF]
Boulmpou A +8 more
europepmc +1 more source
When targeted gene testing falls short: Case report of a novel <i>SLC4A3</i> F347S genetic variant associated with short QT syndrome. [PDF]
Boyd CA +5 more
europepmc +1 more source
Computational analysis of the electromechanical consequences of short QT syndrome
Christopher LH Huang
doaj +1 more source
Interpreting the actionable clinical role of rare variants associated with short QT syndrome. [PDF]
Martínez-Barrios E +13 more
europepmc +1 more source
Delayed diagnosis of short QT syndrome concealed by pacemaker implant due to sick sinus syndrome. [PDF]
Basarici I.
europepmc +1 more source
Alleviating the Effects of Short QT Syndrome Type 3 by Allele-Specific Suppression of the KCNJ2 Mutant Allele. [PDF]
Wilders R.
europepmc +1 more source
Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models. [PDF]
Bodi I +12 more
europepmc +1 more source
Short QT syndrome (January 2013)
Supawat, Ratanapo +7 more
openaire +2 more sources

